SCHEMBL6488475

SCHEMBL6488475

O=C(N1CCC(O)CC1)n1c(-c2cc[nH]n2)cc2ccccc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.35
CA9 Q16790 1/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
HTR2C P28335 2/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
CYP51A1 Q16850 1/20 0.32
SIRT2 Q8IXJ6 1/20 0.32
SIRT1 Q96EB6 1/20 0.32
ACACB O00763 1/20 0.32
ACACA Q13085 1/20 0.32
GRM5 P41594 1/20 0.32
TRPV3 Q8NET8 1/20 0.32
NTRK1 P04629 1/20 0.32
TGM2 P21980 1/20 0.32
NR1H2 P55055 1/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6480498 0.73 CA12 (0.46) CA12CA9KDM4EALDH1A1NR1H2
SCHEMBL6479047 0.65 CA12 (0.42) CA12CA9KDM4EALDH1A1NTRK1
SCHEMBL6488477 0.65 ALDH1A1 (0.42) NPC1RAB9AHTR2CKDM4EALDH1A1
SCHEMBL5754341 0.64 HSP90AA1 (0.41) NPC1RAB9AGRM5L3MBTL1
SCHEMBL5753668 0.64 KDR (0.45) NPC1RAB9AACACBACACAGRM5
SCHEMBL427655 0.60 FAAH (0.69)
SCHEMBL3942903 0.60 L3MBTL3 (0.50) ACACBACACAL3MBTL1
SCHEMBL21391903 0.59 ALDH1A1 (0.38) NPC1RAB9AKDM4EALDH1A1NPSR1
SCHEMBL16002992 0.58 L3MBTL3 (0.43) RAB9AALDH1A1NTRK1L3MBTL1
SCHEMBL27785375 0.58 ALDH1A1 (0.46) NPC1RAB9AALDH1A1GRM5TGM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PHARMACIA ITALIA S.P.A. (IT) 2005-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them MAP3K9, MAP3K20, MAP3K19 CA12 4824/4885CA9 2819/4885NPC1 3439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.